Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis

Immune-checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death-1 (PD-1), and programmed cell death-1-ligand 1 (PD-L1) have become new treatment options for various malignancies. ICIs bind to immune-checkpoint inhibitory receptors or to the foregoing li...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Hiroyuki, Suzuki, Kunihiro, Yanagihara, Toyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533467/
https://www.ncbi.nlm.nih.gov/pubmed/34680601
http://dx.doi.org/10.3390/biomedicines9101484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533467/
https://www.ncbi.nlm.nih.gov/pubmed/34680601
http://dx.doi.org/10.3390/biomedicines9101484

Ejemplares similares